1791 - 1800 out of 1,811Page size: 10
  1. 2002

  2. Gut inflammation and spondyloarthropathies

    de Keyser, F., Baeten, D., van den Bosch, F., de Vos, M., Cuvelier, C., Mielants, H. & Veys, E., 2002, In: Current rheumatology reports. 4, 6, p. 525-532

    Research output: Contribution to journal › Article › Academic › peer-review

  3. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis

    Visser, H., le Cessie, S., Vos, K., Breedveld, F. C. & Hazes, J. M. W., 2002, In: Arthritis and rheumatism. 46, 2, p. 357-365

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Immune linkages between inflammatory bowel disease and spondyloarthropathies

    Baeten, D., de Keyser, F., Mielants, H. & Veys, E. M., 2002, In: Current opinion in rheumatology. 14, 4, p. 342-347

    Research output: Contribution to journal › Review article › Academic › peer-review

  5. Influence of the gut and cytokine patterns in spondyloarthropathy

    Baeten, D., de Keyser, F., van Damme, N., Veys, E. M. & Mielants, H., 2002, In: Clinical and experimental rheumatology. 20, 6 Suppl 28, p. S38-S42

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Interferon-beta for treatment of rheumatoid arthritis?

    van Holten, J., Plater-Zyberk, C. & Tak, P. P., 2002, In: Arthritis research. 4, 6, p. 346-352

    Research output: Contribution to journal › Review article › Academic › peer-review

  7. Is expression of intracellular citrullinated proteins in synovial tissue specific for rheumatoid arthritis? Comment on the article by Baeten et al

    Smeets, T. J. M., Vossenaar, E. R., van Venrooij, W. J. & Tak, P. P., 2002, In: Arthritis and rheumatism. 46, 10, p. 2824-2826

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  8. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup

    Drossaers-Bakker, K. W., Zwinderman, A. H., Vliet Vlieland, T. P. M., van Zeben, D., Vos, K., Breedveld, F. C. & Hazes, J. M. W., 2002, In: Arthritis and rheumatism. 47, 4, p. 383-390

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy

    Baeten, D., Demetter, P., Cuvelier, C. A., Kruithof, E., van Damme, N., de Vos, M., Veys, E. M. & de Keyser, F., 2002, In: Journal of pathology. 196, 3, p. 343-350

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy

    van den Bosch, F., Kruithof, E., Baeten, D., Herssens, A., de Keyser, F., Mielants, H. & Veys, E. M., 2002, In: Arthritis and rheumatism. 46, 3, p. 755-765

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis

    Crotti, T. N., Smith, M. D., Weedon, H., Ahern, M. J., Findlay, D. M., Kraan, M., Tak, P. P. & Haynes, D. R., 2002, In: Annals of the rheumatic diseases. 61, 12, p. 1047-1054

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1...176 177 178 179 180 181 182 Next

ID: 19914